Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. Crucell focuses on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide. Currently they are combating twelve major infectious diseases with their range of marketed vaccines in the paediatric, travel and endemic and respiratory fields.